FDA clearance expands use of the INVOS™ 7100 system, helping clinicians better monitor organ-specific oxygen levels and identify warnings signs for neonates and children earlier "Timing is critical ...
(RTTNews) - Healthcare technology firm Medtronic plc (MDT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its INVOS 7100 cerebral/somatic oximetry ...
GE Healthcare, Medtronic receive FDA 510(k) clearance and CE Mark approval on the integration of advanced INVOS™ regional oximetry and Microstream™ capnography technologies on the CARESCAPE precision ...
An international team of 100 researchers at 70 sites in 17 countries has found no reduction in death for treatment guided by cerebral oximetry monitoring in extremely preterm infants. In the paper ...
Treatment guided by cerebral oximetry monitoring for the first 72 hours after birth failed to improve survival for extremely preterm infants, the SafeBoosC-III trial found. At 36 weeks postmenstrual ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, ...
Medtronic and Mindray North America expanded their partnership on patient monitoring technology beyond hospitals into ASCs in the United States, according to a Jan. 22 news release. The companies said ...
The use of cerebral oximetry monitoring to guide treatment of extremely preterm infants is increasing, yet evidence for its effects on clinical outcomes is lacking. New research findings are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results